Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

SHE:002287 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,374	2,336	2,040	2,040	1,766	1,480
Other Revenue	2.19	2.19	5.55	4.63	4.06	4.58
Revenue	2,376	2,338	2,045	2,045	1,770	1,485
Revenue Growth (YoY)	12.37%	14.32%	0.02%	15.49%	19.22%	5.87%
Cost of Revenue	425.98	419.55	324.7	325.52	269.7	217.36
Gross Profit	1,950	1,918	1,720	1,719	1,501	1,268
Selling, General & Admin	1,294	1,280	1,162	1,107	986.35	828.33
Research & Development	66.18	66.73	58.63	55.09	70.82	60.32
Other Operating Expenses	43.52	34.76	32.26	29.47	28.58	25.68
Operating Expenses	1,404	1,382	1,253	1,192	1,084	915.16
Operating Income	545.75	536.7	467.52	527.71	416.45	352.54
Interest Expense	-67.18	-57.79	-63.07	-56.42	-53.43	-22.31
Interest & Investment Income	-	4.19	41.92	16.96	340.33	58.1
Currency Exchange Gain (Loss)	-0.01	-0.01	-0.03	-0.02	-0.02	-0.11
Other Non Operating Income (Expenses)	-0.66	-0.02	-1.16	-3.56	-2.46	-0.98
EBT Excluding Unusual Items	477.89	483.08	445.19	484.68	700.88	387.24
Impairment of Goodwill	-	-	-	-	-15.77	-
Gain (Loss) on Sale of Investments	87.53	100.32	37.07	-37.08	20.69	-
Gain (Loss) on Sale of Assets	-	-	0.32	0	-0.07	-0.35
Asset Writedown	0.3	-0.58	-0.3	-1.22	-0.35	-0.04
Other Unusual Items	56.26	63.43	162.14	72.82	82.54	58.11
Pretax Income	621.98	646.24	644.41	519.2	787.91	444.96
Income Tax Expense	64.21	64.87	65.24	49.56	77.09	40.78
Earnings From Continuing Operations	557.77	581.37	579.18	469.64	710.83	404.18
Minority Interest in Earnings	2.73	0.91	2.02	2.9	5.05	-0.22
Net Income	560.5	582.28	581.2	472.54	715.88	403.96
Net Income to Common	560.5	582.28	581.2	472.54	715.88	403.96
Net Income Growth	-4.33%	0.19%	22.99%	-33.99%	77.21%	10.90%
Shares Outstanding (Basic)	530	530	530	530	529	529
Shares Outstanding (Diluted)	530	530	530	530	529	529
Shares Change (YoY)	0.05%	0.03%	-0.05%	0.21%	0.12%	0.03%
EPS (Basic)	1.06	1.10	1.10	0.89	1.35	0.76
EPS (Diluted)	1.06	1.10	1.10	0.89	1.35	0.76
EPS Growth	-4.38%	0.15%	23.05%	-34.13%	77.01%	10.87%
Free Cash Flow	647.36	201.31	458.59	13.29	909.35	-101.7
Free Cash Flow Per Share	1.22	0.38	0.86	0.03	1.72	-0.19
Dividend Per Share	0.380	0.380	0.480	0.390	0.590	0.340
Dividend Growth	-20.83%	-20.83%	23.08%	-33.90%	73.53%	-2.86%
Gross Margin	82.07%	82.06%	84.12%	84.08%	84.77%	85.36%
Operating Margin	22.97%	22.96%	22.86%	25.81%	23.52%	23.74%
Profit Margin	23.59%	24.91%	28.42%	23.11%	40.43%	27.20%
Free Cash Flow Margin	27.25%	8.61%	22.42%	0.65%	51.36%	-6.85%
EBITDA	659.39	644.7	552.96	604.13	476.77	396.33
EBITDA Margin	27.75%	27.57%	27.04%	29.54%	26.93%	26.69%
D&A For EBITDA	113.64	108	85.43	76.42	60.32	43.79
EBIT	545.75	536.7	467.52	527.71	416.45	352.54
EBIT Margin	22.97%	22.96%	22.86%	25.81%	23.52%	23.74%
Effective Tax Rate	10.32%	10.04%	10.12%	9.54%	9.78%	9.17%
Revenue as Reported	2,376	2,338	2,045	2,045	1,770	1,485

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.